Studies were conducted to characterize receptors for prostaglandin (PG) F 2 (PGF 2 ) and PGE 2 , and the signalling pathways regulating total nitric oxide synthase activity and progesterone production in rabbit corpora lutea (CL) of different luteal stages. CL were obtained at days 4, 9 and 13 of pseudopregnancy and cultured in vitro for 2 h with PGF 2 or PGE 2 and with activators and inhibitors of G protein (Gp), phospholipase C (PLC), protein kinase C (PKC), adenylate cyclase (AC) and protein kinase A (PKA).
Introduction
There is now considerable direct evidence, derived by both in vivo (Carlson & Gole 1978 , Kehl & Carlson 1981 , Marcinkiewicz et al. 1992 and in vitro studies (O'Grady et al. 1972) , supporting the hypothesis that in the rabbit, as in several other animal species, the major luteolytic hormone is prostaglandin (PG) F 2 (PGF 2 ). However, while there is a general agreement upon the luteolytic role of PGF 2 , there is still some controversy about the mechanisms that protect prostaglandin-induced regression of corpora lutea (CL) in both the early-and mid-luteal phase of pseudopregnancy (Marcinkiewicz et al. 1992 , Boiti et al. 1998 . By contrast, for a long time PGE 2 has been recognized as a luteotrophic prostaglandin, as it may protect the CL from many of the actions induced by PGF 2 (Zelinsky-Wooten & Stouffer 1990 , Ford & Christenson 1991 .
It is also widely accepted that the effects induced by PGs reflect the interactions on target cells with specific surface receptors, and probably with different receptor subtypes, which influence second messenger systems via G protein (Gp) activation. Therefore, the increasing responsiveness of CL to PGF 2 , or its analogues, during subsequent luteal developmental stages (Boiti et al. 1998) , from total to partial refractoriness and complete luteolysis, may be due to changes in the number of receptors for PGF 2 and/or PGE 2 .
Recently we demonstrated, by in vitro studies on CL of pseudopregnant rabbits, that PGF 2 and PGE 2 affect progesterone release differently, depending on the luteal stage, by regulating the activity of nitric oxide synthase (NOS), the enzyme which controls nitric oxide (NO) production (Boiti et al. 2000) . On day 4 CL, PGE 2 was found to depress NOS activity and increase progesterone production, but was totally ineffective on day 9 CL. Prostaglandin F 2 up-regulated NOS activity and induced functional luteolysis in day 9 CL, but had no effect on young CL collected at the early luteal phase.
Several studies have documented a good correlation between in vitro binding specificity and concentrations of prostaglandin receptors for PGF 2 in membranes prepared from CL of several species and its luteolytic activity in vivo (Rao 1974 , Wright et al. 1980 . Additional reports have shown that plasma membrane receptors for PGE 2 in luteal tissue and luteal cells are also related to the functional status of CL during the oestrous cycle and pregnancy (Wiepz et al. 1992 , Feng & Almond 1996 . The presence of PGF 2 and PGE 2 binding sites in both large and small luteal cells has been verified in cow (Alila et al. 1987 , Chegini et al. 1991 ), sheep (Balapure et al. 1989 ) and monkey (Brannian & Stouffer 1991) resulting in some discrepancies probably reflecting species differences (Niswender et al. 1985) . However, the specific binding sites for either PGF 2 or PGE 2 have not been investigated in the rabbit.
The present work was undertaken to examine the affinity and concentration of receptors for PGF 2 and PGE 2 on CL of rabbits in the early-, mid-and late-luteal phase at days 4, 9 and 13 of pseudopregnancy by radioligand binding. These stages of pseudopregnancy were selected because the corresponding CL showed different age-related responsiveness to PGF 2 in vivo (Carlson & Gole 1978 , Marcinkiewicz et al. 1992 , Boiti et al. 1998 . Moreover, to better elucidate the differential age-related effects of PGs and the sites of their functional actions on progesterone release and total NOS activity, the signal transduction pathway was activated in vitro in a stepwise fashion at the level of the receptor (Gp), phospholipase C (PLC) and protein kinase C (PKC), adenylate cyclase (AC) and protein kinase A (PKA). Additionally, the regulatory role of Gps in both luteolytic and luteotrophic actions was studied by adding a number of inhibitors for PLC, PKC, AC and PKA together with a NOS inhibitor (-NAME).
Materials and Methods

Materials
Medium 199 was obtained from Gibco (Grand Island, NY, USA). Hepes, NaHCO 3 , BSA, PGF 2 and PGE 2 were purchased from Sigma (Sigma Chemical Co., St Louis, MO, USA (5, 6, 8, 9, 11, 12, 14, H(N)-PGF 2 , 218 Ci/mmol, NET 433) and [ 3 H]PGE 2 (5, 6, 8, 11, 12, 14, H(N)-PGE 2 , 200 Ci/ mmol, NET 428) were purchased from New England Nuclear (Boston, MA, USA). Tissue culture plates with 24 flat bottom wells were obtained from Becton Dickinson & Co. (Clifton, NJ, USA). Bio-Rad Protein Assay kit was obtained from Bio-Rad Lab (Hercules, CA, USA). The following activators were purchased from Calbiochem Corp. (San Diego, CA, USA): Gp, guanosine 5 -O-(3-thiotriphosphate) (GTP -S); PLC, imipramine; PKC, phorbol-12-myristate-13-acetate (PMA); AC, forskolin, 7-deacetyl-7-[O-(N-methylpiperaziono)--butyryl] (L85 8051); PKA, adenosine 3 ,5 -cyclic monophosphate, . The following inhibitors for Gp, guanosine 5 -O-(2-thiodiphosphate), (GDP -S); PLC, ET-18-OCH 3 ; PKA, compound H89 were also purchased from Calbiochem, while those for PKC, staurosporine, AC, 2-O-methyladenosine, NOS, -NAME came from Sigma. [2, H]-Arginine, having a specific activity of 30-40 Ci/mmol, was purchased from Sigma. Scintillation fluid, Ultima Gold, was obtained from Packard (Groningen, The Netherlands). Multiscreen Assay System and FB Microplate Glass Fiber Type B Filter (MAFB N0B 10) were purchased from Millipore (Molsheim, France). Tris salt, and all reagent ACS grade were also obtained from Sigma. The kit for the assay of NOS (NOS detectTM) was purchased from Alexis (Alexis Corp., Läufelfingen, Switzerland)
Animals, hormonal regimen and tissue collection
All experiments utilized CL obtained from unmated New Zealand White female rabbits (HY/CR, Charles River Italia, Calco, LC, Italy), age 5 months, weighing 3·5-3·8 kg. The animals were kept at the University of Perugia Central Animal Facility under controlled condition of light (14 h light : 10 h darkness) and temperature (18 C), and were given water and commercial pellets and allowed to feed ad libitum.
The rabbits received an i.m. injection of 20 IU pregnant mare serum gonadotrophin (Folligon, Intervet Italia, Milan, Italy) followed 3 days later by an i.m. injection of 0·8 µg gonadotrophin-releasing hormone (GnRH) analogue (Receptal, Roussel-Hoechst, Munich, Germany) to induce pseudopregnancy. The day of GnRH injection was designated day 0. Rabbits were killed on days 4, 9 and 13 of pseudopregnancy by cervical dislocation. CL were promptly removed from the ovary and, immediately upon collection, were washed with saline and then transferred onto filter paper to dissect away the non-luteal tissue with fine forceps under stereoscopic magnification. For each luteal stage, CL from different rabbits were combined together onto ice-cold medium 199 containing 1% BSA and immediately processed for the in vitro study. Additional CL from different rabbits were randomly pooled together on the basis of the day of pseudopregnancy, weighed and stored at -70 C until assayed for prostaglandin receptors.
In vitro incubations
CL from each luteal stage were randomly distributed (one CL/well) into incubation wells containing 1 ml culture medium 199 with Earle's Balanced Salt Solution containing 2·2 mg/ml sodium bicarbonate, 2·3 mg Hepes and 1% BSA, referred to here as M199. For each day of pseudopregnancy, the incubation set of wells was divided into 26 experimental groups. Before treatment, the CL were quartered inside each well using fine forceps. Treatments, performed in four replicate samples, are listed as follows:
(1) control (medium alone), (2) PGE 2 (3 µM), (3) PGE 2 plus Gp inhibitor (Gpi, 2 µM), (4) PGF 2 (3 µM), (5) PGF 2 plus Gpi, and (6) Gpi alone. Additional treatments were (7) Gp activator (Gpa, 0·2 µM), (8) Gpa plus AC inhibitor (ACi 1 µM), (9) Gpa plus PKA inhibitor (PKAi, 2 µM), (10) Gpa plus PLC inhibitor (PLCi, 2 µM), (11) Gpa plus PKC inhibitor (PKCi, 2 µM), (12) Gpa plus NOS inhibitor (NOSi, 1 µM), (13) ACi alone, and (14) PLCi alone. Other treatments were (15) AC activator (ACa, 2 µM), (16) ACa plus PKA inhibitor (2 µM), (17) ACa plus NOSi, (18) PKA activator (PKAa, 2 µM), (19) PKAi, (20) PKAa plus NOSi, (21) PLC activator (PLCa, 2 µM), (22) PLCa plus PKCi, (23) PLCa plus NOSi, (24) PKC activator (PKCa, 2 µM), (25) PKCa plus NOSi, and (26) PKCi alone. The culture plates were incubated at 37 C in air with 5% CO 2 as reported elsewhere (Gobbetti et al. 1999 , Boiti et al. 2000 . CL and media were collected 2 h after the addition of treatments and stored immediately at 20 C for later determination of NOS activity and progesterone levels. Minimum doses of activating substances ( Fig. 1 ) and inhibitors used in the present in vitro study were defined by preliminary experiments.
NOS activity determination
NOS activity was determined in each CL by monitoring the conversion of [ 3 H]-arginine into [
3 H]-citrulline, with a commercial NOS assay kit, according to the experimental protocol as previously described (Boiti et al. 2000) .
Progesterone assay
Progesterone concentrations in the incubation medium samples were determined following the RIA previously reported (Gobbetti et al. 1992) . The assay sensitivities were 10 pg/ml, with a working range of the RIA in culture medium of 1-5 pg/ml. Intra-assay and interassay coefficients of variations were 6% and 11% respectively.
Radio-receptor assays
The PGE 2 and PGF 2 receptor assays were similar to those reported by Wiepz et al. (1992) . Briefly, for each day of pseudopregnancy, 50 mg luteal tissue were homogenized in 5 ml ice-cold homogenization buffer (HB: 10 mM Tris-HCl pH 7·0, containing 250 mM sucrose, 1 mM CaCl 2 , 1 mM MgCl 2 and 0·02% NaN 3 ) with Polytron PT 1200 for five strokes (5 s 2500 r.p.m.) interspersed with 20 s cooling periods. The homogenate was centrifuged at 100 g at 4 C for 15 min. Pellet was discarded and supernatant was centrifuged at 30 000 g at 4 C for 30 min. The resulting pellet was resuspended in 2 ml HB with two strokes of Polytron on ice, and its protein concentration was determined according to the procedure described by Rao et al. (1984) , using a commercial kit. The concentration and affinity of PGF 2 and PGE 2 for specific luteal membrane receptors were assayed by a saturation analysis, using the Multiscreen Assay System device for multiple filtration of unbound radioligands. One hundred micrograms of luteal membrane suspension in 75 µl assay buffer (AB: 10 mM Tris-HCl pH 6·0, containing 10 mM CaCl 2 , 10 mM MgCl 2 , 1·0% BSA and 0·02% NaN 3 ) were dispensed in triplicate into separate wells of a microtitre glass fibre filter plate. Twenty-five microlitres of five serial dilutions of [ 3 H]PGF 2 (2 to 0·125 nM) in AB were then added to each well. The same volume of AB alone or PGF 2 (10 µM) was dispensed to total bound (TB) and non-specific binding series of wells (NSB) respectively. The same protocol scheme was repeated to assay PGE 2 receptor, using [ 3 H]PGE 2 and PGE 2 instead of PGF 2 at the same molar concentrations. The PGF 2 plates were incubated for 2 h at 22 C, while the PGE 2 plates were kept overnight at 4 C. At the end of the incubation period each well was washed three times with 300 µl ice-cold saline. The well filters at the bottom of the microplate were carefully blotted on paper, air-dried and cut into separate microvials using the multiple punch assembly of the Multiscreen device. Three millilitres scintillation fluid were added into each vial and radioactivity was counted on TRICARB 2100 TR liquid scintillation analyser (Packard Camberra). 
Data analysis and statistics
Data for dose-response studies and for effects of treatment on release of progesterone and on basal NOS activity were submitted to ANOVA and Kruskal-Wallis test (Sokal & Rohlf 1981) 
Results
The total NOS activity in rabbit CL cultured with medium alone after 2 h in vitro incubation was lower (Pc0·01) on day 9 CL (10 886 1170 d.p.m./mg wet tissue) than on day 4 and day 13 CL (15 409 1598 and 14 639 1445 respectively). By contrast, at the end of the incubation period, the corresponding basal progesterone production was higher (Pc0·01) on day 9 CL (4970 245 pg/mg wet tissue) than on CL of day 4 and 13 (2781 284 and 3917 569 respectively).
In all CL preparations, independently of their age, the co-treatment with any of the activators here tested and -NAME resulted in an inhibition (Pc0·01) of NOS activity and in a concomitant increase (Pc0·01) of progesterone release (Figs 4 and 5) .
The dose-dependent effects of increasing concentrations of activators for G proteins, AC and PLC added to the incubation medium on both NOS activity and progesterone secretion in CL of different luteal stages after 2 h in vitro incubations are shown in Fig. 1 . Independently of the activators here employed, whenever a response was observed the progesterone release was always inversely related (Pc0·01) to the NOS activity.
Effects of prostaglandins on NOS activity and progesterone production by in vitro cultured CL
On day 4 CL, PGE 2 addition to the medium, at a concentration of 3 µM, decreased (Pc0·01) NOS activity to 16% of control and caused a twofold increase (P c0·01) in progesterone production over that of control (Fig. 2) . The same treatment, however, was ineffective in both mid-and late-phase CL. By contrast, at the end of the incubation period, PGF 2 stimulated a two-to threefold increase (Pc0·01) of NOS baseline activity in rabbit CL tissue preparations of both days 9 and 13 of pseudopregnancy respectively and reduced (Pc0·01) progesterone release to 19-20% of the control (Fig. 2) . However, in CL preparation of day 4, the addition of PGF 2 did not affect progesterone production and NOS activity, which remained unchanged after the same time interval. The specific and age-dependent selective activation of the prostaglandin signal transduction pathways was blocked by the addition of a Gp inhibitor. In fact, independently of the luteal stages, the co-treatments of CL with Gpi and either PGE 2 or PGF 2 failed to induce any response on either total NOS activity or progesterone production, and had values close to those of the corresponding untreated CL or CL treated with Gp inhibitor alone (Fig. 2) .
Effects of in vitro activation of G protein on NOS activity and progesterone release
The addition of 0·2 µM GTP -S, an activator of the G protein family, induced a fivefold decrease (Pc0·01) of basal NOS activity in day 4 CL, but a two-to threefold increase (Pc0·01) in CL of both day 9 and 13 ( Fig. 3) . In the same CL preparations, after 2 h in vitro incubation, progesterone output exhibited an opposite trend (Fig. 3) . In fact, in day 4 CL, steroidogenesis was enhanced (Pc0·01) 228% over that of control as in CL treated with PGE 2 . Conversely, in CL of both days 9 and 13, activation of the Gp system caused a marked decrease (Pc0·01) in progesterone production to values similar to those observed following in vitro PGF 2 treatment.
The co-addition into the culture medium of specific inhibitors for the AC system blocked the Gpa-induced effects on both NOS activity and progesterone release of day 4 CL, while inhibitors of the PLC system did not affect Gpa-mediated effects (Fig. 3) . Conversely, in CL of both days 9 and 13, PLC inhibitor counteracted the Gpa-induced effects, while AC inhibitor was ineffective (Fig. 3) . Similar luteal stage dependent results were obtained by co-treatments of Gpa with PKA and PKC inhibitors (data not shown). Incubations of CL with AC and PLC inhibitors had no effects (Fig. 3) .
Effects of in vitro activation of AC/PKA system on NOS activity and progesterone release
The stimulation of the AC/PKA cascade by the addition of either forskolin or 8-bromo-cAMP down-regulated NOS activity in CL of days 4, 9 and 13 (Fig. 4) . In day 4 CL, the effects induced by in vitro activation of the AC/PKA system overlapped that evoked by PGE 2 . By contrast, in mid-and late-luteal phase CL, the inhibition of NOS activity was much higher (Pc0·01) than in day 4 CL and similar to that obtained in CL co-treated with the NOS inhibitor, -NAME. On day 4 CL, the effects of both AC and PKA activators mimicked PGE 2 treatment by increasing basal progesterone secretion 223% over that of control, while on day 9 CL the luteotrophic effect was less effective as progesterone production rose (Pc0·01) only 50% over that of controls (Fig. 4) . Conversely, in day 13 CL progesterone release remained unaffected by treatments with both AC and PKA activators. In CL of all ages, the co-treatment with PKA inhibitor abolished the luteotrophic effect induced by the AC activator by restoring NOS activity and progesterone release to their respective basal control values (Fig. 4) . Treatment with PKA inhibitor alone had no effect on both NOS activity and progesterone release (Fig. 4) .
Effects of in vitro activation of PLC/PKC system on NOS activity and progesterone release
The in vitro treatments with either the PLC or the PKC system activator greatly decreased (Pc0·01) progesterone production by CL preparations independently of their age (Fig. 5) . The effects on the NOS activity induced by these treatments were opposed and caused a two-to threefold increase (Pc0·01) of basal NOS activity over that of controls (Fig. 5) . The co-addition of the PKC inhibitor to CL treated with PLC activator abolished the luteolytic effect and the up-regulation of NOS activity. Similar results were obtained by treatment with PKC inhibitor alone. In fact, both progesterone release and total NOS activity remained unchanged, having values close to those found in control CL of the same ages (Fig. 5) .
Binding affinities and concentrations of PGF 2 and PGE 2 receptors
Saturation curves and Scatchard plot transformations derived by binding isotherms for each prostaglandin in the different luteal stages are shown in Fig. 6 . Independently of the luteal stages, the concentrations of receptor sites for PGF 2 were greater than the concentrations for PGE 2 receptors, but increased markedly over those for PGE 2 from twofold on day 4 CL to 15-fold on CL of both midand late-luteal stages (Fig. 7) . The concentration of receptors for PGF 2 increased (Pc0·01) four-to fivefold from early to mid-and late-luteal phase, being highest on day 13 CL. By contrast, on day 4 CL the concentration of receptors for PGE 2 was highest (Pc0·01) compared with lower values found in older CL. In CL of mid-luteal phase, the dissociation constants (K d ) for the receptors for PGE 2 and PGF 2 were 1·6 0·5 and 1·9 06 nM respectively. Similar values were obtained also in CL of early and late-luteal phases. For each prostaglandin, slope factors for the competition curves were not statistically different from 1, suggesting a ligand receptor interaction that could be explained by a one-site binding model.
Discussion
Although the involvement of receptors for both PGF 2 and PGE 2 has been postulated in CL of pseudopregnant rabbits on the basis of their luteolytic and luteotrophic actions (Boiti et al. 2000) , this work is the first direct evidence for their existence in this species. Independently of CL age, luteal cells have now been clearly shown to display luteal membrane binding sites for these PGs. Under the assay conditions used for this study, the binding characteristics suggest a one-site model for each receptor. However, while the capacity of PGF 2 receptors increased markedly over time with the ageing of CL, by contrast the number of binding sites of the PGE 2 receptors decreased progressively from early-to late-luteal phase.
Several studies have identified receptors for both PGE 2 and PGF 2 and their distribution in luteal cells of different species including laboratory rodents and farm animals. Wright et al. (1980) found that affinity and capacity of PGF 2 receptors in CL of rats do not change across pseudopregnancy. High-affinity PGF 2 binding sites have been found in bovine CL already in the early luteal phase (Sakamoto et al. 1995 , Wiltbank et al. 1995 when CL are usually resistant to single treatment with exogenous PGF 2 . Moreover, Sakamoto et al. (1994 Sakamoto et al. ( , 1995 showed that the expression of mRNA for luteal membrane PGF 2 receptors and the number and affinity of their binding sites increased only slightly during the oestrous cycle of the bovine. These findings differ from those previously reported by Rao (1974) , who demonstrated a marked increase in the affinity of the PGF 2 receptor of bovine CL, which parallels the increase in sensitivity to PGF 2 -induced luteolysis during the bovine oestrous cycle. In pigs, PGE 2 receptor concentration appeared to be related to CL functional status during the oestrous cycle (Feng & Almond 1996) . Therefore, considerable differences among species exist in the ways receptors for PGs change during the time-course of the CL life span, a feature that adds complexity to the underlying regulatory mechanisms which probably involve also intraluteal factors (Skarzynski & Okuda 1999) . Several reports suggest a role of G proteins in the signalling pathways involved in the transduction of prostaglandin actions. The effects of PGF 2 -receptor activation appear to be transduced by the Gp family and those of PGE 2 by interaction with a stimulatory Gp (Olofsson & Leung 1996) . This role has been indirectly confirmed here by the lack of specific prostaglandin-induced responses following the co-application of Gp inhibitors and either PGE 2 or PGF 2 to CL in vitro and by the mimicking effects obtained by the addition of Gp activators. The Gpdependent AC/PKA pathway, regulating NOS enzymatic activity and steroidogenesis, was triggered only on day 4 CL. In older CL, the Gp-activated PLC/PKC pathway prevailed. In CL of both days 9 and 13, activation of the G protein system evoked a marked luteolytic effect similar to that observed following treatment with PGF 2 . This prostaglandin has been shown to mediate functional luteolysis and luteal regression in the mammalian ovary, with the relevant exception of man and other primates (Niswender et al. 2000) . In ovaries from both human and other primate species, however, PGF 2 does indeed activate the phospholipase C signalling pathway (Davis et al. 1989) . The luteolytic action of PGF 2 in rabbit CL depends upon the availability of functional receptors on target luteal cells and, following receptor binding, appears to be mediated by several mechanisms integrating a number of second messengers such as PLC and PKC phosphorylation in signal transduction. Prostaglandin F 2 -receptor occupations in both day 9 and day 13 CL cultured in vitro rapidly stimulated total NOS activity and inhibited progesterone, thus confirming our previous results (Gobbetti et al. 1999 , Boiti et al. 2000 . In our model, independently of the luteal stages, whenever total NOSlike activity was significantly up-regulated, a functional luteolytic response was observed as evidenced by a marked reduction of progesterone production. The signalling pathway leading to luteolysis was interrupted by incubation with -NAME. These findings strongly support the hypothesis for a functional role of NO in the PGF 2 -mediated luteolytic process in rabbit CL. A key role in the regulation of NOS activity should be attributed to Ca 2+ mobilization, which increases its free intracellular levels following PGF 2 -receptor occupation. In fact, it is well established that constitutive endothelial NOS requires Ca 2+ for the reversible binding of calmodulin to the enzyme to become active and generate NO (Bredt & Snyder 1990) . PGF 2 rapidly induces an increase in phosphoinositide turnover by PLC and, consequently, a rise in intracellular diacylglycerol (DAG) and inositol triphosphate (InP 3 ) levels; DAG activates PKC while InP 3 frees intracellular Ca 2+ (Wiltbank et al. 1991) . Conversely, the activation of the receptor for PGE 2 , EP 2 is associated with elevation of intracellular levels of cAMP (Olofsson & Leung 1986) .
Studies of prostaglandin actions in vitro have often yielded contradictory results on the production of progesterone. In contrast to our present findings, McLean et al. (1987) reported that neither PGF 2 nor PGE 2 altered progesterone secretion by dispersed luteal cells obtained from rabbits at day 10 of pseudopregnancy. Dharmarajan et al. (1989) found that PGF 2 did not affect progesterone production in the in vitro perfused rabbit ovary in vitro at day 11 of pseudopregnancy. These discrepancies are mainly related to the difference in the in vitro technique used. It remains to be established, however, if the increased progesterone release is due to an actual synthesis rather than to a leakage from dying cells as suggested by Dharmarajan et al. (1994 Dharmarajan et al. ( , 1999 who reported that rabbit CL undergo spontaneous apoptosis within a few hours when cultured in serum-free medium.
The luteolytic action of PGF 2 was clearly dependent on the age of the CL. Four-day-old CL remained unaffected by the same luteolytic dose of PGF 2 which caused a striking reduction in progesterone production by mature CL. On the basis of the binding studies here reported, the age-dependent unresponsiveness of young CL may be the combined results of fewer functional receptors available for PGF 2 associated with an increase in the number of receptors for PGE 2 conveying luteotrophic or antiluteolytic signals. In fact, it has been shown that PGF 2 can bind to receptors for PGE 2 (Christenson et al. 1994 , Coleman 1996 . Although the low receptor density for PGF 2 may well explain the resistance to this prostaglandin in the early luteal stage, an impairment of Gp coupled to PGF 2 receptor could not be ruled out. In fact, the addition into the culture medium of activators for either PLC and PKC enzymes caused a marked luteolytic effect not only on day 9 and day 13 CL, similar to that obtained by PGF 2 treatment, but also in day 4 CL, when the same prostaglandin was completely ineffective. The increasing PGF 2 receptor density occurring in the midand late-luteal stages of pseudopregnancy is consistent with the luteolytic effects observed in vitro, which involve interaction of the CL and PGF 2 itself. Rabbits, however, are completely refractory to PGF 2 injection until day 12 of pseudopregnancy (Marcinkiewicz et al. 1992) , even if they exhibit earlier responsiveness to the PGF 2 analogue, alfaprostol (Boiti et al. 1998) . The lack of response to PGF 2 in vivo before day 12 of pseudopregnancy is therefore unlikely to be caused by a reduced expression of binding sites for PGF 2 , and suggests the involvement of other factors.
In several species, PGE 2 has been identified as a luteotrophic factor and it is supposed to counteract PGF 2 -induced luteolysis (Henderson et al. 1977 , Silvia et al. 1984 . PGE 2 has been involved in the maintenance of the CL during early pregnancy when progesterone secretion from the CL is essential for the establishment and maintenance of pregnancy (Christenson et al. 1994) . According to Grimes et al. (1993) , PGE 2 enhances progesterone synthesis via cAMP stimulation, as well as the expression of the genes for both steroidogenic enzymes 3 -hydroxysteroid dehydrogenase (3 -HSD) and mitochondrial cytochrome P450 scc (Li et al. 1993) . Our in vitro study demonstrated direct PGE 2 -receptor-mediated effects in CL of pseudopregnant rabbits only in the early luteal phase. In fact, PGE 2 -stimulated progesterone production was abolished by co-incubation with Gp inhibitor, while similar results were obtained when Gp activator was used. On day 4 CL, the action on luteal cell steroidogenesis following binding is exerted at multiple sites and probably involves AC and PKA up-regulation. In fact, cAMPderivative and PKA-activator likewise stimulated progesterone releases by CL of the same age. That the effect is at least partially exerted through cAMP-mediated mechanisms is further supported by the findings that PGE 2 -induced progesterone release was abolished by cotreatments with inhibitors of the AC/PKA systems. As previously stated, the stimulatory action of PGE 2 was found to be present only on day 4 CL, while, thereafter in mature CL, a positive response was not observed. Interestingly, a similar differential responsiveness to PGE 2 has also been reported in monkey; incubation with this prostaglandin increased progesterone production by luteal cells obtained from CL in the early phase of the menstrual cycle on days 3-5, but was ineffective in subsequent stages (Brannian & Stouffer 1991) . However, the absence of any PGE 2 -induced luteotrophic effects in rabbit CL at days 9 and 13 seems not to be associated with a complete lack of luteal membrane PGE 2 receptors. The unresponsiveness of both day 9 and day 13 CL to PGE 2 could also be ascribed to prior in vivo desensitization to PGE 2 receptor or to receptor uncoupling from AC. Taken together, these results suggest that PGE 2 may not have a relevant role in CL of either mid-or late-luteal stages of pseudopregnancy. However, even if PGE 2 enhances progesterone production only in the early luteal phase, AC/cAMP and PKA second messenger systems, working in a luteotrophic or luteoprotective fashion, are present in CL of both mid-and late-luteal phases. Notably, maximal stimulation of progesterone production occurred on day 9 CL in the presence of AC and PKA activators. Even if 17 -oestradiol has been identified as the principal luteotrophic hormone, rabbit CL exhibit LH receptors, LH-responsive AC and a cAMP-dependent protein kinase enzyme system which is specifically activated in a time-and a dose-dependent manner (Hunzicker-Dunn & Birnbaumer 1976 , Hoyer et al. 1986 .
In the present study we demonstrated that the receptor capacity of both PGF 2 and PGE 2 changes in CL of pseudopregnant rabbits during the luteal phases. However, the factors that may influence the increased expression of PGF 2 receptor during pseudopregnancy while reducing that of PGE 2 , remain to be explored. Differential binding capacities of PGF 2 and PGE 2 receptors between earlyand both mid-and late-luteal stages may reflect functional differences not yet understood and in this respect it would be interesting to compare their characteristics in relation to physiological conditions of pregnancy and pseudopregnancy. The mechanisms by which the CL of rabbit are refractory to the luteolytic action of PGF 2 during the early period of pseudopregnancy remain to be disclosed and better characterized, but are probably mediated by factors other than a complete lack of luteal receptor-ligand interactions. The combined results of this study provide further evidence that the contrasting prostaglandininduced luteolytic and luteotrophic effects observed in rabbit CL cultured in vitro are mediated by different receptors for PGF 2 and PGE 2 coupled to Gp families. Moreover, this study confirms that PLC/PKC and AC/ PKA systems play an important role in the transduction of signals regulating prostaglandin-induced luteolytic and luteotrophic effects respectively. 
